Pfizer CFO Dave Denton to step down Aug 15; Cecile Guegan named interim CFO

PFIZER INC

Dave Denton to step down as CFO effective August 15, 2026, for a consumer goods opportunity.
Departure not related to Pfizer's financial or operating results or any disagreements.
Cecile Guegan, SVP Finance, Global Biopharm Business, named interim CFO effective August 16.
Pfizer will conduct internal and external search for permanent CFO.
Guegan has over 20 years at Pfizer, led Seagen integration.

item 5.02 item 9.01

Featured in Daily 8-K Digest

Selected #1 for 2026-06-18. Read digest

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Cecile Guegan

Interim Chief Financial Officer

PFE · PFIZER INC

Effective: 2026-08-16
Filed: June 18, 2026, 7:07 AM ET

the Company announced that Cecile Guegan, the Company’s Senior Vice President, Finance, Global Biopharmaceutical Business, will serve as Interim Chief Financial Officer, effective August 16, 2026

Departed (interim)

Dave Denton

Chief Financial Officer

PFE · PFIZER INC

Effective: 2026-08-15
Successor: Cecile Guegan
Filed: June 18, 2026, 7:07 AM ET

Dave Denton notified Pfizer Inc. (the “Company”) that he will step down from his current position as Chief Financial Officer effective August 15, 2026

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Cecile Guegan was appointed as Interim Chief Financial Officer at PFIZER INC.

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

the Company announced that Cecile Guegan, the Company’s Senior Vice President, Finance, Global Biopharmaceutical Business, will serve as Interim Chief Financial Officer, effective August 16, 2026

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dave Denton departed as Chief Financial Officer at PFIZER INC.

Action: step down
Role: Chief Financial Officer

Exact text from the filing

Dave Denton notified Pfizer Inc. (the “Company”) that he will step down from his current position as Chief Financial Officer effective August 15, 2026

View on SEC.gov

PFIZER INC filing history →

Source: SEC EDGAR

accession 0000078003-26-000085

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.